CN103478527A - Low-glycemic-index nutrient powder - Google Patents
Low-glycemic-index nutrient powder Download PDFInfo
- Publication number
- CN103478527A CN103478527A CN201310373185.6A CN201310373185A CN103478527A CN 103478527 A CN103478527 A CN 103478527A CN 201310373185 A CN201310373185 A CN 201310373185A CN 103478527 A CN103478527 A CN 103478527A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- dietary fiber
- hypoglycemia patient
- powder
- nutritious powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000843 powder Substances 0.000 title claims abstract description 58
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 22
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 52
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 44
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 44
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 44
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 31
- 239000011707 mineral Substances 0.000 claims abstract description 31
- 235000010755 mineral Nutrition 0.000 claims abstract description 31
- 229940088594 vitamin Drugs 0.000 claims abstract description 31
- 229930003231 vitamin Natural products 0.000 claims abstract description 31
- 235000013343 vitamin Nutrition 0.000 claims abstract description 31
- 239000011782 vitamin Substances 0.000 claims abstract description 31
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 30
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 30
- 238000006116 polymerization reaction Methods 0.000 claims abstract description 25
- 239000002994 raw material Substances 0.000 claims abstract description 21
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 17
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 15
- 239000008158 vegetable oil Substances 0.000 claims abstract description 15
- 230000002218 hypoglycaemic effect Effects 0.000 claims description 47
- 208000013016 Hypoglycemia Diseases 0.000 claims description 42
- 235000008935 nutritious Nutrition 0.000 claims description 37
- 235000018102 proteins Nutrition 0.000 claims description 29
- 229920001202 Inulin Polymers 0.000 claims description 21
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 21
- 229940029339 inulin Drugs 0.000 claims description 21
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 20
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 20
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 20
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 20
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 20
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 20
- 239000005862 Whey Substances 0.000 claims description 20
- 102000007544 Whey Proteins Human genes 0.000 claims description 20
- 108010046377 Whey Proteins Proteins 0.000 claims description 20
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 20
- 239000004376 Sucralose Substances 0.000 claims description 15
- 235000019408 sucralose Nutrition 0.000 claims description 15
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 15
- 230000001954 sterilising effect Effects 0.000 claims description 12
- 238000004659 sterilization and disinfection Methods 0.000 claims description 12
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 10
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 10
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 10
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 10
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 10
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 10
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 10
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 10
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 10
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 10
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 10
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 10
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 10
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 10
- 229930003268 Vitamin C Natural products 0.000 claims description 10
- 229930003316 Vitamin D Natural products 0.000 claims description 10
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 10
- 229930003427 Vitamin E Natural products 0.000 claims description 10
- 229930003448 Vitamin K Natural products 0.000 claims description 10
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 10
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 10
- 229960002685 biotin Drugs 0.000 claims description 10
- 235000020958 biotin Nutrition 0.000 claims description 10
- 239000011616 biotin Substances 0.000 claims description 10
- 239000011575 calcium Substances 0.000 claims description 10
- 229910052791 calcium Inorganic materials 0.000 claims description 10
- 239000000460 chlorine Substances 0.000 claims description 10
- 229910052801 chlorine Inorganic materials 0.000 claims description 10
- 229910052804 chromium Inorganic materials 0.000 claims description 10
- 239000011651 chromium Substances 0.000 claims description 10
- 229910052802 copper Inorganic materials 0.000 claims description 10
- 239000010949 copper Substances 0.000 claims description 10
- 229960000304 folic acid Drugs 0.000 claims description 10
- 235000019152 folic acid Nutrition 0.000 claims description 10
- 239000011724 folic acid Substances 0.000 claims description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 10
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 10
- 229960000367 inositol Drugs 0.000 claims description 10
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 10
- 229910052742 iron Inorganic materials 0.000 claims description 10
- 239000011777 magnesium Substances 0.000 claims description 10
- 229910052749 magnesium Inorganic materials 0.000 claims description 10
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 10
- 229910052750 molybdenum Inorganic materials 0.000 claims description 10
- 239000011733 molybdenum Substances 0.000 claims description 10
- 235000001968 nicotinic acid Nutrition 0.000 claims description 10
- 229960003512 nicotinic acid Drugs 0.000 claims description 10
- 239000011664 nicotinic acid Substances 0.000 claims description 10
- 229940055726 pantothenic acid Drugs 0.000 claims description 10
- 235000019161 pantothenic acid Nutrition 0.000 claims description 10
- 239000011713 pantothenic acid Substances 0.000 claims description 10
- 239000011574 phosphorus Substances 0.000 claims description 10
- 229910052698 phosphorus Inorganic materials 0.000 claims description 10
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 10
- 239000011591 potassium Substances 0.000 claims description 10
- 229910052700 potassium Inorganic materials 0.000 claims description 10
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 10
- 229910052708 sodium Inorganic materials 0.000 claims description 10
- 239000011734 sodium Substances 0.000 claims description 10
- 239000003549 soybean oil Substances 0.000 claims description 10
- 235000012424 soybean oil Nutrition 0.000 claims description 10
- 235000019155 vitamin A Nutrition 0.000 claims description 10
- 239000011719 vitamin A Substances 0.000 claims description 10
- 235000019154 vitamin C Nutrition 0.000 claims description 10
- 239000011718 vitamin C Substances 0.000 claims description 10
- 235000019166 vitamin D Nutrition 0.000 claims description 10
- 239000011710 vitamin D Substances 0.000 claims description 10
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 10
- 235000019165 vitamin E Nutrition 0.000 claims description 10
- 229940046009 vitamin E Drugs 0.000 claims description 10
- 239000011709 vitamin E Substances 0.000 claims description 10
- 235000019168 vitamin K Nutrition 0.000 claims description 10
- 239000011712 vitamin K Substances 0.000 claims description 10
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 10
- 229940045997 vitamin a Drugs 0.000 claims description 10
- 229940046008 vitamin d Drugs 0.000 claims description 10
- 229940046010 vitamin k Drugs 0.000 claims description 10
- 239000011701 zinc Substances 0.000 claims description 10
- 229910052725 zinc Inorganic materials 0.000 claims description 10
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 8
- 235000019486 Sunflower oil Nutrition 0.000 claims description 8
- 239000002600 sunflower oil Substances 0.000 claims description 8
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 6
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 6
- 235000003599 food sweetener Nutrition 0.000 claims description 5
- 239000003765 sweetening agent Substances 0.000 claims description 5
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 4
- 235000019483 Peanut oil Nutrition 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 239000000312 peanut oil Substances 0.000 claims description 3
- -1 FSPC Proteins 0.000 claims description 2
- 108010073771 Soybean Proteins Proteins 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- 239000003240 coconut oil Substances 0.000 claims description 2
- 235000019864 coconut oil Nutrition 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- 239000000835 fiber Substances 0.000 claims description 2
- 235000019710 soybean protein Nutrition 0.000 claims description 2
- 238000010410 dusting Methods 0.000 claims 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 8
- 230000002641 glycemic effect Effects 0.000 abstract description 6
- 235000012000 cholesterol Nutrition 0.000 abstract description 4
- 239000000194 fatty acid Substances 0.000 abstract description 4
- 150000004671 saturated fatty acids Chemical class 0.000 abstract description 4
- 235000004213 low-fat Nutrition 0.000 abstract description 3
- 235000014113 dietary fatty acids Nutrition 0.000 abstract description 2
- 229930195729 fatty acid Natural products 0.000 abstract description 2
- 150000004665 fatty acids Chemical class 0.000 abstract description 2
- 235000013376 functional food Nutrition 0.000 abstract description 2
- 230000007547 defect Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 9
- 206010012601 diabetes mellitus Diseases 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 238000001694 spray drying Methods 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 229920000294 Resistant starch Polymers 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- 235000021254 resistant starch Nutrition 0.000 description 5
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 239000000428 dust Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000036186 satiety Effects 0.000 description 3
- 235000019627 satiety Nutrition 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 208000001280 Prediabetic State Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000036996 cardiovascular health Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000020185 raw untreated milk Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000021262 sour milk Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention relates to the field of functional food, particularly a low-glycemic-index nutrient powder. The low-glycemic-index nutrient powder comprises the following raw materials in percentage by weight: 5-35% of dietary fiber with the polymerization degree of 10-50, 2-7% of dietary fiber with the polymerization degree of 2-9, 30-35% of nonresistant maltodextrin, 10-30% of protein, 5-10% of vegetable oil, 0.5-2% of mineral and 0.5-2% of vitamin. In order to overcome the defects in the prior art, the invention provides a nutrient powder capable of effectively lowering the glycemic index; the formula has the characteristics of high dietary fiber content, low fat content and low saturated fatty acid content, and is free of cholesterol and trans fatty acid; and the low glycemic index is less than or equal to 25.
Description
Technical field
The present invention relates to field of functional food, particularly, the present invention relates to a kind of nutritious powder for hypoglycemia patient.
Background technology
The world today, along with the acceleration of rapid economic development and process of industrialization, the NCD that human health faces threatens just day by day serious, wherein the more serious health that is threatening people of diabetes and thing followed complication.According to IDF, add up, diabetes mellitus in China crowd quantity occupies 1/3 of the whole world, the investigation result of 2008 shows, in the adult more than 20 years old, the illness rate of the diabetes of age markization is 9.7%, and the ratio of prediabetes is more up to 15.5%, being equivalent to just has a hyperglycemic patients in every four adults.The diabetic is except outside the Pass small part and congenital heredity factor have, and most of main and too much to take at ordinary times the food of higher fatty acid, high heat, high protein relevant, therefore, the hypoglycemia patient food of the applicable patients with diabetes mellitus of exploitation is significant.
Patent CN102613289A discloses a kind of hypoglycemic Yoghourt, comprises dairy products are equipped with to stabilizing agent, generation sugar, inulin, through strain fermentation, makes.Yet this sour milk products be not suitable for the diabetic as every day main meals taken, be only suitable for, in as before the meal or leisure food after the meal, thering is certain application limitation.
Patent 200510009679.1 has been announced a kind of hypoglycemic nutrient powder, comprises raw milk, soy meal, FSPC, oligoisomaltose, fructose, resistant starch and soluble dietary fiber.Yet, in formula, the high-load of resistant starch and soluble dietary fiber only has 5%, the high-load of oligoisomaltose is 15%, although resistant starch and soluble dietary fiber and oligoisomaltose have certain similar action, as increase feces volume and increase the quantity of beneficial bacterium in enteron aisle, but, resistant starch and soluble dietary fiber are only to play and fall hypoglycemic main matter, have the food of a large amount of resistant starches and soluble dietary fiber can be in small intestine imbibition increase people's satiety, can make again carbohydrate and fat slowly decompose digestion simultaneously in small intestine, reduce glucose content in human blood thereby play, and the absorption of minimizing low-density lipoprotein.
Summary of the invention
The present invention, for addressing the above problem, for the prior art deficiency, provides a kind of nutritious powder for hypoglycemia patient.
Nutritious powder for hypoglycemia patient of the present invention, raw materials by weight comprises:
The dietary fiber 5%-35% that the degree of polymerization (DP) is 10-50, the dietary fiber 2%-7% that the degree of polymerization (DP) is 2-9, non-resistance maltodextrin (not the common maltodextrin of anti-enzymolysis) 30%-55%, protein 10%-30%, vegetable oil 5%-10%, mineral matter 0.5%-2% and vitamin 0.5%-2%.
According to nutritious powder for hypoglycemia patient of the present invention, preferably, described nutrient powder raw materials by weight comprises:
The dietary fiber 5%-35% that the degree of polymerization is 30-50, the dietary fiber 2%-7% that the degree of polymerization is 2-9, non-resistance maltodextrin 30%-55%, protein 10%-30%, vegetable oil 5%-10%, mineral matter 0.5%-2% and vitamin 0.5%-2%.
Further, the dietary fiber addition that the dietary fiber that the above-mentioned degree of polymerization is 10-50 or the degree of polymerization are 30-50 is preferably 20%～30%, and more preferably 25%～30%.
According to nutritious powder for hypoglycemia patient of the present invention, wherein, the dietary fiber that the dietary fiber that the described degree of polymerization is 10-50 or the degree of polymerization are 30-50 is resistant maltodextrin.Described resistant maltodextrin derives from corn.
Resistant maltodextrin used in the present invention, comprise that Isosorbide-5-Nitrae-glycosidic bond accounts for 50%～88%, 1, and the 6-glycosidic bond accounts for 10%～30%, 1, and the 2-glycosidic bond accounts for 1%～10%, 1, and the 3-glycosidic bond accounts for 1%～15%.It has following characteristic:
High fiber content: reach more than 95%;
Highly-water-soluble: solubility reaches (20 ℃) more than 80%;
High stability: heat-resisting, acidproof;
High moisture resistivity: do not lump;
Low in calories: 1.0Kcal/g.
According to nutritious powder for hypoglycemia patient of the present invention, wherein, the dietary fiber that the described degree of polymerization is 2-9 is one or more in inulin, FOS, galactooligosaccharide and xylo-oligosaccharide.Be preferably the combination of 1%-4% inulin and 1%-3% FOS.
According to nutritious powder for hypoglycemia patient of the present invention, wherein, described protein is one or more in whey isolate protein, FSPC, soybean protein isolate, WPC.The combination of the whey isolate protein that to be preferably protein be 5%-15% and the FSPC of 5%-15%.
According to nutritious powder for hypoglycemia patient of the present invention, wherein, described vegetable oil is one or more in rapeseed oil, soybean oil, sunflower oil, peanut oil and coconut oil.
According to nutritious powder for hypoglycemia patient of the present invention, wherein, described mineral matter is selected from one or more in sodium, potassium, copper, magnesium, iron, zinc, manganese, calcium, chlorine, phosphorus, iodine, chromium and molybdenum.
According to nutritious powder for hypoglycemia patient of the present invention, described vitamin is selected from vitamin A, vitamin D, vitamin E, vitamin K, Cobastab
1, Cobastab
2, Cobastab
6, Cobastab
12, one or more in vitamin C, biotin, nicotinic acid, pantothenic acid, folic acid and inositol.
According to nutritious powder for hypoglycemia patient of the present invention, wherein, described nutrient powder can also comprise the sweetener that is less than or equal to 5%, and described sweetener is preferably used Sucralose, and consumption is for being less than or equal to 0.1%.
Preferred sweeteners is selected from one or more in Sucralose, acesulfame potassium, Aspartame.
Nutritious powder for hypoglycemia patient of the present invention, total fatty shared percentage composition<10%, the shared percentage composition of saturated fatty acid<1.5%, not containing cholesterol and trans-fatty acid, and the glycemic index of nutrient powder≤25.
The method of the above-mentioned nutritious powder for hypoglycemia patient of preparation of the present invention, steps such as comprising batching, homogeneous, sterilization, concentrate and dust.
Particularly, comprise the following steps:
1, batching: 45 ℃-50 ℃ of mixture temperatures add the solution that water is mixed with 20%-30%;
2, homogenization pressure: one-level 110bar, secondary 35bar;
3, sterilization: 92 ℃ of temperature, 15 seconds;
4, concentrated: as to be concentrated into dry matter content 48%;
5, dust: EAT: 175 ℃-190 ℃, temperature of outgoing air: 80 ℃-90 ℃.
The present invention is directed to the prior art weak point, invented a nutrient powder that can effectively reduce glycemic index, formula has high dietary fiber content, low-fat content, low saturated fatty acid content, does not contain the characteristics of cholesterol and trans-fatty acid, hypoglycemia patient≤25.High dietary fiber content can increase people's satiety, reduces the absorption of energy, can increase the quantity of beneficial bacterium in large intestine simultaneously, and then improve function of intestinal canal; Low-fat content, low saturated fatty acid content, containing cholesterol, be not of value to and control body weight and cardiovascular health.It is edible as main meals that this nutrient powder is suitable for the diabetes patient.
The dietary fiber that the degree of polymerization is high can delay the digestion rate of food in human gastrointestinal tract, postpones the digestion rate of digestibility carbohydrate, the digestion of delay glucose and absorption.Dietary fiber can also strengthen the sensitiveness of insulin, directly affects pancreatic islet alpha-cell function, improves the regulating action of insulin in blood, improves the anti-sugared degree of human body, is conducive to treatment and the recovery of diabetes.
In dietary fiber 1,6-glycosidic bond, 1,3-glycosidic bond, 1, the quantity of 2-glycosidic bond has determined its special efficacy aspect hypoglycemic, especially 1, and 6-glycosidic bond quantity is even more important, generally, the dietary fiber that 1,6-glycosidic bond quantity is more is more obvious in the effect aspect hypoglycemic.This is mainly because 1,6-glycosidic bond, 1,3-glycosidic bond, 1, the existence of 2-glycosidic bond, make dietary fiber have network structure, the digestive ferment that such DFS is difficult in body decomposes, and in human body, expands, increase the human body satiety, also reduced the digestion rate of other foods in human body simultaneously.
The dietary fiber that the degree of polymerization is low also is not easy to digested, control to blood sugar for human body also can play a role, simultaneously, the low polymerization degree dietary fiber is the Major Nutrient material of beneficial flora in human body intestinal canal, growth and breeding to probio plays important physiological action, regulates functions of intestines and stomach by probio and finally plays the effect that strengthens body immunity.
The present invention is by adding the dietary fiber of a certain amount of low polymerization degree, on the one hand the dietary fiber of a certain proportion of low polymerization degree structurally can in and the harmful effect that enteron aisle is produced of high polymerization degree dietary fiber, on the other hand, the dietary fiber of the low polymerization degree added can increase probio quantity in enteron aisle, help improve to a certain extent the digestive function of enteron aisle, and the enhancing body immunity, the mid-aged population that especially is applicable to hyperglycaemia is edible.
The specific embodiment
Embodiment 1
With dietary fiber (resistant maltodextrin, DP value 42), non-resistance maltodextrin, whey isolate protein, FSPC, vegetable oil, inulin, FOS, Sucralose, minerals and vitamins are raw material, be mixed with pure water the solution that concentration is 25%, through homogeneous, sterilization, concentrated, spray-drying, make nutritious powder for hypoglycemia patient.
Above-mentioned resistant maltodextrin comprises: Isosorbide-5-Nitrae-glycosidic bond accounts for 57.5%, 1, and the 6-glycosidic bond accounts for 26%, 1, and the 2-glycosidic bond accounts for 4.3%, 1, and the 3-glycosidic bond accounts for 12.2%.
Concrete preparation process is as follows:
1, batching: 45 ℃-50 ℃ of mixture temperatures add pure water and are mixed with 25% solution;
2, homogenization pressure: one-level 110bar, secondary 35bar;
3, sterilization: 92 ℃ of temperature, 15 seconds;
4, concentrated: as to be concentrated into dry matter content 48%;
5, dust: EAT: 175 ℃-190 ℃, temperature of outgoing air: 80 ℃-90 ℃.
Wherein the consumption of each raw material is: dietary fiber 29kg, non-resistance maltodextrin 34kg, whey isolate protein 13kg, FSPC 7kg, rapeseed oil 2kg, soybean oil 4kg, inulin 2kg, FOS 2kg, Sucralose 0.5kg, mineral matter 1.5kg and vitamin 2kg.
Described mineral matter is selected from one or more in sodium, potassium, copper, magnesium, iron, zinc, manganese, calcium, chlorine, phosphorus, iodine, chromium and molybdenum.
Described vitamin is selected from vitamin A, vitamin D, vitamin E, vitamin K, Cobastab
1, Cobastab
2, Cobastab
6, Cobastab
12, one or more in vitamin C, biotin, nicotinic acid, pantothenic acid, folic acid and inositol.
Embodiment 2
With dietary fiber (resistant maltodextrin, DP value 30), non-resistance maltodextrin, whey isolate protein, FSPC, vegetable oil, inulin, FOS, Sucralose, minerals and vitamins are raw material, be mixed with pure water the solution that concentration is 20%, through homogeneous, sterilization, concentrated, spray-drying, make nutritious powder for hypoglycemia patient.Concrete preparation process is with embodiment 1.
Above-mentioned resistant maltodextrin comprises: Isosorbide-5-Nitrae-glycosidic bond accounts for 65%, 1, and the 6-glycosidic bond accounts for 19%, 1, and the 2-glycosidic bond accounts for 4%, 1, and the 3-glycosidic bond accounts for 12%.
Wherein the consumption of each raw material is: dietary fiber 25kg, non-resistance maltodextrin 32kg, whey isolate protein 7kg, FSPC 15kg, rapeseed oil 1kg, soybean oil 3kg, sunflower oil 2kg, inulin 4kg, FOS 1kg, Sucralose 0.5kg, mineral matter 1.5kg and vitamin 1.5kg.
Described mineral matter is selected from one or more in sodium, potassium, copper, magnesium, iron, zinc, manganese, calcium, chlorine, phosphorus, iodine, chromium and molybdenum.
Described vitamin is selected from vitamin A, vitamin D, vitamin E, vitamin K, Cobastab
1, Cobastab
2, Cobastab
6, Cobastab
12, one or more in vitamin C, biotin, nicotinic acid, pantothenic acid, folic acid and inositol.
Embodiment 3
With dietary fiber (resistant maltodextrin, DP value 50), non-resistance maltodextrin, whey isolate protein, FSPC, vegetable oil, inulin, FOS, Sucralose, minerals and vitamins are raw material, be mixed with pure water the solution that concentration is 25%, through homogeneous, sterilization, concentrated, spray-drying, make nutritious powder for hypoglycemia patient.Concrete preparation process is with embodiment 1.
Above-mentioned resistant maltodextrin comprises: Isosorbide-5-Nitrae-glycosidic bond accounts for 59%, 1, and the 6-glycosidic bond accounts for 30%, 1, and the 2-glycosidic bond accounts for 1%, 1, and the 3-glycosidic bond accounts for 10%.
Wherein the consumption of each raw material is: dietary fiber 30kg, non-resistance maltodextrin 35kg, whey isolate protein 8kg, FSPC 10kg, soybean oil 4kg, sunflower oil 1kg, inulin 1kg, galactooligosaccharide 3kg, Sucralose 0.5kg, each 0.5kg of minerals and vitamins.
Described mineral matter is selected from one or more in sodium, potassium, copper, magnesium, iron, zinc, manganese, calcium, chlorine, phosphorus, iodine, chromium and molybdenum.
Described vitamin is selected from vitamin A, vitamin D, vitamin E, vitamin K, Cobastab
1, Cobastab
2, Cobastab
6, Cobastab
12, one or more in vitamin C, biotin, nicotinic acid, pantothenic acid, folic acid and inositol.
Embodiment 4
With dietary fiber (resistant maltodextrin, DP value 38), non-resistance maltodextrin, whey isolate protein, FSPC, vegetable oil, inulin, FOS, Sucralose, minerals and vitamins are raw material, be mixed with pure water the solution that concentration is 30%, through homogeneous, sterilization, concentrated, spray-drying, make nutritious powder for hypoglycemia patient.Concrete preparation process is with embodiment 1.
Above-mentioned resistant maltodextrin comprises: Isosorbide-5-Nitrae-glycosidic bond accounts for 68.1%, 1, and the 6-glycosidic bond accounts for 23%, 1, and the 2-glycosidic bond accounts for 7.9%, 1, and the 3-glycosidic bond accounts for 1%.
Wherein the consumption of each raw material is: dietary fiber 25kg, non-resistance maltodextrin 35kg, whey isolate protein 17kg, FSPC 8kg, rapeseed oil 1kg, soybean oil 3kg, sunflower oil 1kg, inulin 2kg, xylo-oligosaccharide 1kg, Sucralose 0.5kg, each 2kg of minerals and vitamins.
Described mineral matter is selected from one or more in sodium, potassium, copper, magnesium, iron, zinc, manganese, calcium, chlorine, phosphorus, iodine, chromium and molybdenum.
Described vitamin is selected from vitamin A, vitamin D, vitamin E, vitamin K, Cobastab
1, Cobastab
2, Cobastab
6, Cobastab
12, one or more in vitamin C, biotin, nicotinic acid, pantothenic acid, folic acid and inositol.
Embodiment 5
With dietary fiber (resistant maltodextrin, DP value 35), non-resistance maltodextrin, whey isolate protein, FSPC, vegetable oil, inulin, FOS, Sucralose, minerals and vitamins are raw material, be mixed with pure water the solution that concentration is 25%, through homogeneous, sterilization, concentrated, spray-drying, make nutritious powder for hypoglycemia patient.Concrete preparation process is with embodiment 1.
Above-mentioned resistant maltodextrin comprises: Isosorbide-5-Nitrae-glycosidic bond accounts for 66.9%, 1, and the 6-glycosidic bond accounts for 21%, 1, and the 2-glycosidic bond accounts for 3.2%, 1, and the 3-glycosidic bond accounts for 8.9%.Please supplement.
Wherein the consumption of each raw material is: dietary fiber 25kg, non-resistance maltodextrin 35kg, whey isolate protein 5kg, FSPC 14kg, soybean oil 5kg, peanut oil 5kg, inulin 4kg, xylo-oligosaccharide 3kg, each 2kg of minerals and vitamins.
Described mineral matter is selected from one or more in sodium, potassium, copper, magnesium, iron, zinc, manganese, calcium, chlorine, phosphorus, iodine, chromium and molybdenum.
Described vitamin is selected from vitamin A, vitamin D, vitamin E, vitamin K, Cobastab
1, Cobastab
2, Cobastab
6, Cobastab
12, one or more in vitamin C, biotin, nicotinic acid, pantothenic acid, folic acid and inositol.
Embodiment 6
With dietary fiber (resistant maltodextrin, DP value 40), non-resistance maltodextrin, whey isolate protein, FSPC, vegetable oil, inulin, FOS, Sucralose, minerals and vitamins are raw material, be mixed with pure water the solution that concentration is 30%, through homogeneous, sterilization, concentrated, spray-drying, make nutritious powder for hypoglycemia patient.Concrete preparation process is with embodiment 1.
Above-mentioned resistant maltodextrin comprises: Isosorbide-5-Nitrae-glycosidic bond accounts for 57.8%, 1, and the 6-glycosidic bond accounts for 25%, 1, and the 2-glycosidic bond accounts for 6.7%, 1, and the 3-glycosidic bond accounts for 10.5%.Please supplement.
Wherein the consumption of each raw material is: dietary fiber 30kg, non-resistance maltodextrin 30kg, whey isolate protein 15kg, FSPC 15kg, rapeseed oil 2kg, soybean oil 3kg, sunflower oil 2kg, inulin 1kg, galactooligosaccharide 1kg, each 0.5kg of minerals and vitamins.
Described mineral matter is selected from one or more in sodium, potassium, copper, magnesium, iron, zinc, manganese, calcium, chlorine, phosphorus, iodine, chromium and molybdenum.
Described vitamin is selected from vitamin A, vitamin D, vitamin E, vitamin K, Cobastab
1, Cobastab
2, Cobastab
6, Cobastab
12, one or more in vitamin C, biotin, nicotinic acid, pantothenic acid, folic acid and inositol.
Embodiment 7
With dietary fiber (resistant maltodextrin, DP value 15), non-resistance maltodextrin, whey isolate protein, FSPC, vegetable oil, inulin, FOS, Sucralose, minerals and vitamins are raw material, be mixed with pure water the solution that concentration is 30%, through homogeneous, sterilization, concentrated, spray-drying, make nutritious powder for hypoglycemia patient.Concrete preparation process is with embodiment 1.
Above-mentioned resistant maltodextrin comprises: Isosorbide-5-Nitrae-glycosidic bond accounts for 77%, 1, and the 6-glycosidic bond accounts for 10%, 1, and the 2-glycosidic bond accounts for 10%, 1, and the 3-glycosidic bond accounts for 3%.
Wherein the consumption of each raw material is: dietary fiber 5kg, non-resistance maltodextrin 55kg, whey isolate protein 15kg, FSPC 15kg, rapeseed oil 2kg, soybean oil 3kg, sunflower oil 2kg, inulin 1kg, galactooligosaccharide 1kg, each 0.5kg of minerals and vitamins.
Described mineral matter is selected from one or more in sodium, potassium, copper, magnesium, iron, zinc, manganese, calcium, chlorine, phosphorus, iodine, chromium and molybdenum.
Described vitamin is selected from vitamin A, vitamin D, vitamin E, vitamin K, Cobastab
1, Cobastab
2, Cobastab
6, Cobastab
12, one or more in vitamin C, biotin, nicotinic acid, pantothenic acid, folic acid and inositol.
Embodiment 8
With dietary fiber (resistant maltodextrin, DP value 10), non-resistance maltodextrin, whey isolate protein, FSPC, vegetable oil, inulin, FOS, Sucralose, minerals and vitamins are raw material, be mixed with pure water the solution that concentration is 30%, through homogeneous, sterilization, concentrated, spray-drying, make nutritious powder for hypoglycemia patient.Concrete preparation process is with embodiment 1.
Above-mentioned resistant maltodextrin comprises: Isosorbide-5-Nitrae-glycosidic bond accounts for 67%, 1, and the 6-glycosidic bond accounts for 15%, 1, and the 2-glycosidic bond accounts for 3%, 1, and the 3-glycosidic bond accounts for 15%.
Wherein the consumption of each raw material is: dietary fiber 15kg, non-resistance maltodextrin 45kg, whey isolate protein 15kg, FSPC 15kg, rapeseed oil 2kg, soybean oil 3kg, sunflower oil 2kg, inulin 1kg, galactooligosaccharide 1kg, each 0.5kg of minerals and vitamins.
Described mineral matter is selected from one or more in sodium, potassium, copper, magnesium, iron, zinc, manganese, calcium, chlorine, phosphorus, iodine, chromium and molybdenum.
Described vitamin is selected from vitamin A, vitamin D, vitamin E, vitamin K, Cobastab
1, Cobastab
2, Cobastab
6, Cobastab
12, one or more in vitamin C, biotin, nicotinic acid, pantothenic acid, folic acid and inositol.
Embodiment 9
Buy commercially available have obtain nutrient powder in the nutrient powder that reduces the blood sugar effect and the embodiment of the present invention and carry out clinical trial, measure the glycemic index of these products.
Glycemic index (GI) refers to that the experimenter is edible containing after the food of 50g carbohydrate, blood glucose response TG-AUC (AUC) and edible from blood glucose response TG-AUC percentage after standard food (being generally glucose) equivalent carbohydrate.
Select 8 volunteers that meet health requirements to carry out clinical trial, test comprises nutrient powder in 1 glucose solution, 8 embodiment and 3 commercially available totally 11 samples with nutrient powder of effect of lowering blood sugar respectively.A sample of test in every three days, before each test, the volunteer wants 12 hours on an empty stomach, need to gather 7 times blood sample during each test, eating immediately the test product containing the 50g carbohydrate after blood sampling for the first time, the 15th, 30,45,60,90,120 minutes difference blood sample collections after eating, measure the blood-sugar content in these 7 blood sample samples, and draw the blood glucose response curve.
The test average result is as follows:
| The sample title | The GI value |
| Embodiment 1 | 21.5 |
| Embodiment 2 | 23.1 |
| Embodiment 3 | 20.6 |
| Embodiment 4 | 22.4 |
| Embodiment 5 | 22.9 |
| Embodiment 6 | 21.8 |
| Embodiment 7 | 25 |
| Embodiment 8 | 24.2 |
| Commercially available hypoglycemia nutrient powder | 35.7 |
| Commercially available hypoglycemia nutrient powder | 38.5 |
| Commercially available hypoglycemia nutrient powder | 42.3 |
By result, can find, the GI value of the nutritious powder for hypoglycemia patient in the embodiment of the present invention all is less than or equal to 25, is better than commercially available competing product low-glycemic nutrient powder on effect of lowering blood sugar.
Claims (14)
1. a nutritious powder for hypoglycemia patient, is characterized in that, described nutrient powder raw materials by weight comprises:
The dietary fiber 5%-35% that the degree of polymerization is 10-50, the fiber 2%-7% that the degree of polymerization is 2-9, non-resistance maltodextrin 30%-55%, protein 10%-30%, vegetable oil 5%-10%, mineral matter 0.5%-2% and vitamin 0.5%-2%.
2. nutritious powder for hypoglycemia patient according to claim 1, is characterized in that, described nutrient powder raw materials by weight comprises:
The dietary fiber 5%-35% that the degree of polymerization is 30-50, the dietary fiber 2%-7% that the degree of polymerization is 2-9, non-resistance maltodextrin 30%-55%, protein 10%-30%, vegetable oil 5%-10%, mineral matter 0.5%-2% and vitamin 0.5%-2%.
3. nutritious powder for hypoglycemia patient according to claim 1 and 2, it is characterized in that, the dietary fiber that the described degree of polymerization is 10-50 or 30-50 is resistant maltodextrin, described resistant maltodextrin comprises: 1,4-glycosidic bond 50%～88%, 1,6-glycosidic bond 10%～30%, 1,2-glycosidic bond 1%～10%, 1,3-glycosidic bond 1%～15%.
4. nutritious powder for hypoglycemia patient according to claim 3, is characterized in that, described resistant maltodextrin derives from corn.
5. nutritious powder for hypoglycemia patient according to claim 1, is characterized in that, the dietary fiber that the described degree of polymerization is 2-9 is one or more in inulin, FOS, galactooligosaccharide and xylo-oligosaccharide.
6. nutritious powder for hypoglycemia patient according to claim 5, is characterized in that, the combination that the dietary fiber that the described degree of polymerization is 2-9 is 1%-4% inulin and 1%-3% FOS.
7. nutritious powder for hypoglycemia patient according to claim 1, is characterized in that, described protein is one or more in whey isolate protein, FSPC, soybean protein isolate, WPC.
8. nutritious powder for hypoglycemia patient according to claim 1, is characterized in that, the combination of the whey isolate protein that described protein is 5%-15% and the FSPC of 5%-15%.
9. nutritious powder for hypoglycemia patient according to claim 1, is characterized in that, described vegetable oil is one or more in rapeseed oil, soybean oil, sunflower oil, peanut oil and coconut oil.
10. nutritious powder for hypoglycemia patient according to claim 1, is characterized in that, described mineral matter is selected from one or more in sodium, potassium, copper, magnesium, iron, zinc, manganese, calcium, chlorine, phosphorus, iodine, chromium and molybdenum.
11. nutritious powder for hypoglycemia patient according to claim 1, is characterized in that, described vitamin is selected from vitamin A, vitamin D, vitamin E, vitamin K, Cobastab
1, Cobastab
2, Cobastab
6, Cobastab
12, one or more in vitamin C, biotin, nicotinic acid, pantothenic acid, folic acid and inositol.
12. nutritious powder for hypoglycemia patient according to claim 1, is characterized in that, described nutrient powder also comprises the sweetener that is less than or equal to 5%.
13. according to the described nutritious powder for hypoglycemia patient of claim 1 or 12, it is characterized in that, described sweetener is to be less than or equal to 0.1% Sucralose.
14. a method for preparing the described nutritious powder for hypoglycemia patient of claim 1, comprise batching, homogeneous, sterilization, the concentrated and step of dusting.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310373185.6A CN103478527B (en) | 2013-08-23 | 2013-08-23 | A kind of nutritious powder for hypoglycemia patient |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310373185.6A CN103478527B (en) | 2013-08-23 | 2013-08-23 | A kind of nutritious powder for hypoglycemia patient |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103478527A true CN103478527A (en) | 2014-01-01 |
| CN103478527B CN103478527B (en) | 2015-10-21 |
Family
ID=49819389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310373185.6A Active CN103478527B (en) | 2013-08-23 | 2013-08-23 | A kind of nutritious powder for hypoglycemia patient |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103478527B (en) |
Cited By (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104026446A (en) * | 2014-05-15 | 2014-09-10 | 广东省农业科学院蚕业与农产品加工研究所 | Nutritional meal replacement powder suitable for crowd with hyperglycemia and preparation method thereof |
| CN104187624A (en) * | 2014-08-07 | 2014-12-10 | 逯明福 | Comprehensive nutrition powder and preparation method thereof |
| CN105212228A (en) * | 2015-11-12 | 2016-01-06 | 华东理工大学 | A kind of nutritious powder for hypoglycemia patient |
| CN105410689A (en) * | 2015-10-27 | 2016-03-23 | 广东省农业科学院蚕业与农产品加工研究所 | Special meal food suitable for nutrient mode of diabetes and nephropathy and making method of special meal food |
| CN106036815A (en) * | 2016-02-23 | 2016-10-26 | 广州安远医药科技有限公司 | Nutritional support composition for rehabilitation of postoperative patient |
| CN106072530A (en) * | 2016-06-18 | 2016-11-09 | 江苏阜丰生物科技有限公司 | A kind of full nutritional formulas of anti-protein allergies |
| ITUB20153138A1 (en) * | 2015-08-17 | 2017-02-17 | Antonio Polimeno | ? Composition in the form of semi-finished food for use in the food processing industry, composed of food raw materials and formulated for the production of ice creams, desserts and confectionery products in general, functionally suitable to reduce the rise in blood glucose after carbohydrate consumption ? |
| CN107072276A (en) * | 2014-09-01 | 2017-08-18 | 马修·乔利·瓦达科姆里 | A kind of nutraceutical of optimization |
| CN107373332A (en) * | 2017-09-06 | 2017-11-24 | 郑家福 | It is not added with full cereal fruit-vegetable powder of fortification of white granulated sugar and milk powder and preparation method thereof |
| CN107467573A (en) * | 2017-08-25 | 2017-12-15 | 武汉华康臣生物科技有限公司 | A kind of lycopene extraction method and special diet tomato nutrient powder |
| CN107912776A (en) * | 2016-10-09 | 2018-04-17 | 内蒙古伊利实业集团股份有限公司 | A kind of edible composition and its application for aiding in reducing the glycemic index of food |
| CN108142951A (en) * | 2018-01-31 | 2018-06-12 | 广州纽健生物科技有限公司 | Improve nutraceutical of postoperative insulin resistance and its preparation method and application |
| CN108208802A (en) * | 2017-12-31 | 2018-06-29 | 西安凯伦生物科技有限公司 | A kind of special diet of suitable patients with diabetes mellitus and preparation method thereof |
| CN108713743A (en) * | 2018-05-24 | 2018-10-30 | 中南林业科技大学 | A kind of preparation method of low GI meal replacement powders |
| CN109430382A (en) * | 2018-11-12 | 2019-03-08 | 贝因美（杭州）食品研究院有限公司 | It is a kind of to have effects that adjust the formula food and preparation method thereof of blood glucose |
| CN109452645A (en) * | 2018-12-27 | 2019-03-12 | 山东禹王生态食业有限公司 | A kind of full nutrient formulation powder of high protein and preparation method thereof |
| CN109805377A (en) * | 2019-02-28 | 2019-05-28 | 黑龙江阳光工业大麻研究院 | A kind of hypoglycemic special medicine purposes formula food and preparation method thereof |
| CN110122862A (en) * | 2019-05-31 | 2019-08-16 | 广东双骏生物科技有限公司 | A kind of special medicine purposes food and preparation method thereof reducing blood glucose |
| CN110801027A (en) * | 2018-11-19 | 2020-02-18 | 合肥工业大学 | Dietary fiber composition |
| CN112273440A (en) * | 2020-09-16 | 2021-01-29 | 内蒙古欧世蒙牛乳制品有限责任公司 | Low-GI composition and low-GI milk powder with blood sugar balancing effect |
| CN113317496A (en) * | 2021-06-04 | 2021-08-31 | 西安力邦临床营养股份有限公司 | Emulsion with special medical application for relieving diabetes symptoms and preparation method thereof |
| CN116548606A (en) * | 2022-01-30 | 2023-08-08 | 中国农业大学 | Nutritional composition suitable for serving as pre-meal load and capable of relieving and increasing sugar and feeling of satiety and application of nutritional composition |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102687750A (en) * | 2012-06-13 | 2012-09-26 | 杭州诺伽特健康科技有限公司 | Weight losing and meal replacement protein type solid beverage |
| CN102771690A (en) * | 2012-07-06 | 2012-11-14 | 张文彪 | Muscle building functional food |
| CN102872452A (en) * | 2012-09-21 | 2013-01-16 | 中国人民解放军第三军医大学第三附属医院 | Low sodium and low potassium enteral total nutrient |
-
2013
- 2013-08-23 CN CN201310373185.6A patent/CN103478527B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102687750A (en) * | 2012-06-13 | 2012-09-26 | 杭州诺伽特健康科技有限公司 | Weight losing and meal replacement protein type solid beverage |
| CN102771690A (en) * | 2012-07-06 | 2012-11-14 | 张文彪 | Muscle building functional food |
| CN102872452A (en) * | 2012-09-21 | 2013-01-16 | 中国人民解放军第三军医大学第三附属医院 | Low sodium and low potassium enteral total nutrient |
Non-Patent Citations (2)
| Title |
|---|
| 张平 等: "菊粉水溶性膳食纤维对便秘的作用", 《食品安全导刊》, no. 7, 15 July 2013 (2013-07-15), pages 58 - 59 * |
| 滕健 等: "抗性麦芽糊精研究进展", 《粮食与饲料工业》, no. 4, 15 April 2012 (2012-04-15) * |
Cited By (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104026446A (en) * | 2014-05-15 | 2014-09-10 | 广东省农业科学院蚕业与农产品加工研究所 | Nutritional meal replacement powder suitable for crowd with hyperglycemia and preparation method thereof |
| CN104026446B (en) * | 2014-05-15 | 2016-08-24 | 广东省农业科学院蚕业与农产品加工研究所 | A kind of it is suitable for nutritional meal replacement powder that hyperglycemia population takes and preparation method thereof |
| CN104187624A (en) * | 2014-08-07 | 2014-12-10 | 逯明福 | Comprehensive nutrition powder and preparation method thereof |
| CN104187624B (en) * | 2014-08-07 | 2016-06-08 | 逯明福 | Comprehensive nutrition powder and its preparation method |
| CN107072276A (en) * | 2014-09-01 | 2017-08-18 | 马修·乔利·瓦达科姆里 | A kind of nutraceutical of optimization |
| ITUB20153138A1 (en) * | 2015-08-17 | 2017-02-17 | Antonio Polimeno | ? Composition in the form of semi-finished food for use in the food processing industry, composed of food raw materials and formulated for the production of ice creams, desserts and confectionery products in general, functionally suitable to reduce the rise in blood glucose after carbohydrate consumption ? |
| CN105410689A (en) * | 2015-10-27 | 2016-03-23 | 广东省农业科学院蚕业与农产品加工研究所 | Special meal food suitable for nutrient mode of diabetes and nephropathy and making method of special meal food |
| CN105212228A (en) * | 2015-11-12 | 2016-01-06 | 华东理工大学 | A kind of nutritious powder for hypoglycemia patient |
| CN106036815A (en) * | 2016-02-23 | 2016-10-26 | 广州安远医药科技有限公司 | Nutritional support composition for rehabilitation of postoperative patient |
| CN106072530A (en) * | 2016-06-18 | 2016-11-09 | 江苏阜丰生物科技有限公司 | A kind of full nutritional formulas of anti-protein allergies |
| CN107912776A (en) * | 2016-10-09 | 2018-04-17 | 内蒙古伊利实业集团股份有限公司 | A kind of edible composition and its application for aiding in reducing the glycemic index of food |
| CN107467573A (en) * | 2017-08-25 | 2017-12-15 | 武汉华康臣生物科技有限公司 | A kind of lycopene extraction method and special diet tomato nutrient powder |
| CN107373332A (en) * | 2017-09-06 | 2017-11-24 | 郑家福 | It is not added with full cereal fruit-vegetable powder of fortification of white granulated sugar and milk powder and preparation method thereof |
| CN108208802A (en) * | 2017-12-31 | 2018-06-29 | 西安凯伦生物科技有限公司 | A kind of special diet of suitable patients with diabetes mellitus and preparation method thereof |
| CN108142951A (en) * | 2018-01-31 | 2018-06-12 | 广州纽健生物科技有限公司 | Improve nutraceutical of postoperative insulin resistance and its preparation method and application |
| CN108713743A (en) * | 2018-05-24 | 2018-10-30 | 中南林业科技大学 | A kind of preparation method of low GI meal replacement powders |
| CN109430382A (en) * | 2018-11-12 | 2019-03-08 | 贝因美（杭州）食品研究院有限公司 | It is a kind of to have effects that adjust the formula food and preparation method thereof of blood glucose |
| CN110801027A (en) * | 2018-11-19 | 2020-02-18 | 合肥工业大学 | Dietary fiber composition |
| CN109452645A (en) * | 2018-12-27 | 2019-03-12 | 山东禹王生态食业有限公司 | A kind of full nutrient formulation powder of high protein and preparation method thereof |
| CN109805377A (en) * | 2019-02-28 | 2019-05-28 | 黑龙江阳光工业大麻研究院 | A kind of hypoglycemic special medicine purposes formula food and preparation method thereof |
| CN110122862A (en) * | 2019-05-31 | 2019-08-16 | 广东双骏生物科技有限公司 | A kind of special medicine purposes food and preparation method thereof reducing blood glucose |
| CN112273440A (en) * | 2020-09-16 | 2021-01-29 | 内蒙古欧世蒙牛乳制品有限责任公司 | Low-GI composition and low-GI milk powder with blood sugar balancing effect |
| CN113317496A (en) * | 2021-06-04 | 2021-08-31 | 西安力邦临床营养股份有限公司 | Emulsion with special medical application for relieving diabetes symptoms and preparation method thereof |
| CN116548606A (en) * | 2022-01-30 | 2023-08-08 | 中国农业大学 | Nutritional composition suitable for serving as pre-meal load and capable of relieving and increasing sugar and feeling of satiety and application of nutritional composition |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103478527B (en) | 2015-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103478527B (en) | A kind of nutritious powder for hypoglycemia patient | |
| CN104872558A (en) | Low-GI (glycemic index) brewing porridge and preparing method thereof | |
| CN103653170B (en) | Stachyose probiotics solid beverage | |
| CN101283816B (en) | Instant kelp food and processing method thereof | |
| CN111011862B (en) | Edible composition, low glycemic index nutrition powder and preparation method thereof | |
| CN105360891A (en) | Flour having low glycemic index and making method thereof | |
| CN103169006B (en) | Baby nutrition noodles and preparation method thereof | |
| CN102630948A (en) | High-fiber sugar-free fruit flavored type compound prebiotics and preparation method thereof | |
| CN101822281A (en) | L-arabinose functional biscuit and manufacturing method thereof | |
| CN105166759A (en) | Coconut powder containing high dietary fiber and application of coconut powder | |
| CN106820069A (en) | A kind of natural built-up sweetener with regulating intestinal canal function and preparation method thereof | |
| CN111406800A (en) | Low-GI yogurt suitable for diabetics and preparation method thereof | |
| CN107912776A (en) | A kind of edible composition and its application for aiding in reducing the glycemic index of food | |
| CN101336654A (en) | Tartary tuckwheat vegetable noodle | |
| CN101874615B (en) | Production method of food capable of reducing after-dinner blood sugar of diabetes patients | |
| CN109007719A (en) | A kind of control sugar-type jelly and preparation method thereof | |
| CN102125240B (en) | Perpetration method of konjaku can and konjaku can prepared by using same | |
| Chou et al. | The effect of high‐pressure processing on reducing the glycaemic index of atemoya puree | |
| CN105831587A (en) | Sugar-control tartary buckwheat steamed bread and preparing method | |
| CN101874614A (en) | Nutrition powder composition used for diabetics | |
| Liang et al. | Sugar loss attributed to non-enzymatic browning corresponds to reduce calories recovered in low-molecular-weight fraction | |
| EP3416502B1 (en) | Glycemic reducing composition | |
| CN109007586A (en) | A kind of health nutritious noodle | |
| CN111202107A (en) | Purple sweet potato rock tea biscuits with low GI value and preparation method thereof | |
| CN104970102A (en) | Making method of functional vegetable protein beverage with L-arabinose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |